Hatching Brilliant Solutions
Get healthier, more productive flocks now.
Superior Flock Protection
Innovax, our leading range of HVT construct vaccines for respiratory challenges, provides superior, long-term protection against infectious poultry diseases to optimize flock health and increase productivity.
BREAKTHROUGH
Biotechnical solutions improve flock immunity.
REACTION-FREE
Reaction-free with long-term protection.
MORE EFFICIENT
More efficient disease control to enhance productivity.
ON-GOING SUPPORT
Ongoing support program for producers optimizes profitability.
Breakthrough Innovation
Merck Animal Health is at the forefront of researching and developing new ways to expand protection for the poultry industry. Innovax vaccines are developed by scientists in our research centers using the latest biotechnology. They are manufactured sustainably in our controlled sites across the world.
With 6,000 people in over 150 countries worldwide, including 750 scientists, 18 research centers and 25 production sites, Merck Animal Health is committed to improving poultry protection to help you produce more. This commitment is strong with breakthrough innovation in both the DNA single and the new dual construct vaccines now offering 3-in-1 protection.
Hatching Brilliant Solutions
Innovax is our pioneering range of vaccines for serious poultry challenges. Its foundation is the herpesvirus of turkey (HVT), known to be safe for chickens. HVT not only helps prevent diseases, such as Marek’s disease, it also acts as a carrier for other antigens that stimulate immunity, such as Newcastle disease, removing the need for live vaccines. This contrasts with traditional vaccines which introduce attenuated live viruses and can cause adverse reaction.
Innovax delivers superior, long-term protection against infectious poultry diseases to optimize flock health and performance. The Innovax range of vaccines provides safe, reaction-free vaccination against infectious diseases that threaten flock productivity world-wide, including infectious bursal disease (IBD), Newcastle disease (ND), infectious laryngotracheitis (ILT) and Marek’s disease (MD).
